REPATHA (Evolocumab)-140mg

Repatha (Evolocumab) is a human monoclonal antibody that works by helping the liver reduce levels of “bad” cholesterol (low-density lipoprotein, or LDL) circulating in your blood.

Repatha is a treatment in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery. It helps the liver clear LDL bad cholesterol by limiting the actions of a protein called PCSK9—and less PCSK9 means less LDL in your blood.